0001209191-19-046892.txt : 20190820 0001209191-19-046892.hdr.sgml : 20190820 20190820190058 ACCESSION NUMBER: 0001209191-19-046892 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190816 FILED AS OF DATE: 20190820 DATE AS OF CHANGE: 20190820 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ANDERSON TIMOTHY B CENTRAL INDEX KEY: 0001124168 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21937 FILM NUMBER: 191041009 MAIL ADDRESS: STREET 1: C/O JAN STERN REED BAXTER INTERNATIONAL STREET 2: ONE BAXTER PARKWAY DF2 2W CITY: DEERFIELD STATE: IL ZIP: 60015 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CERUS CORP CENTRAL INDEX KEY: 0001020214 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 680262011 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1220 CONCORD AVENUE STREET 2: SUITE 600 CITY: CONCORD STATE: CA ZIP: 94520 BUSINESS PHONE: 9252886000 MAIL ADDRESS: STREET 1: 1220 CONCORD AVENUE STREET 2: SUITE 600 CITY: CONCORD STATE: CA ZIP: 94520 FORMER COMPANY: FORMER CONFORMED NAME: CERUS TECHNOLOGIES INC DATE OF NAME CHANGE: 19960731 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-08-16 0 0001020214 CERUS CORP CERS 0001124168 ANDERSON TIMOTHY B C/O CERUS CORPORATION 2550 STANWELL DRIVE CONCORD CA 94520 1 0 0 0 Common Stock 2019-08-16 4 M 0 19000 2.62 A 177649 D Common Stock 2019-08-16 4 S 0 9664 5.25 D 167985 D Common Stock 2019-08-19 4 M 0 16487 2.62 A 184472 D Common Stock 2019-08-19 4 S 0 7931 5.55 D 176541 D Common Stock 2019-08-19 4 M 0 2518 2.62 A 179059 D Common Stock 2019-08-19 4 S 0 1200 5.6017 D 177859 D Option (Right to Buy) 2.62 2019-08-16 4 M 0 19000 D 2027-06-06 Common Stock 19000 19005 D Option (Right to Buy) 2.62 2019-08-19 4 M 0 16487 D 2027-06-06 Common Stock 16487 2518 D Option (Right to Buy) 2.62 2019-08-19 4 M 0 2518 D 2027-06-06 Common Stock 2518 0 D The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.605 to $5.600 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. The option shall vested in twelve (12) equal monthly installments on each monthly anniversary of the vesting commencement date with the final vesting date being the earlier of (a) one year from the date of grant, or (b) the day prior to the 2018 Annual Meeting of Stockholders. Not applicable. Timothy B. Anderson by Chrystal Menard, attorney-in-fact 2019-08-20